alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 919.350 What must I do if I learn of information required under § 919.335 after entering into a covered transaction with the OPM? At any time after you enter into a covered transaction, you must give immediate written notice to the OPM office with which you entered into the transaction if you learn either that— ( a ) You failed to disclose information earlier, as required by § 919.335; or
( b ) Due to changed circumstances, you or any of the principals for the transaction now meet any of the criteria in § 919.335.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Fellowships in Digestive Diseases and Nutrition.                    

*Date:*                         February 14-15, 2019.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814.                    

*Contact Person:*                         Jian Yang, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7111, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-7799,                         *yangj@extra.niddk.nih.gov.*

This meeting notice is being published less than 15 days in advance of the meeting due to the partial Government shutdown of December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

Dated: January 25, 2019.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2019-00345 Filed 1-30-19; 8:45 am]

 BILLING CODE 4140-01-P
[Federal Register Volume 69, Number 219 (Monday, November 15, 2004)]
[Notices]
[Page 65599]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-25268]



[[Page 65599]]

-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Formations of, Acquisitions by, and Mergers of Bank Holding 
Companies

    The companies listed in this notice have applied to the Board for 
approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 
1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other 
applicable statutes and regulations to become a bank holding company 
and/or to acquire the assets or the ownership of, control of, or the 
power to vote shares of a bank or bank holding company and all of the 
banks and nonbanking companies owned by the bank holding company, 
including the companies listed below.
    The applications listed below, as well as other related filings 
required by the Board, are available for immediate inspection at the 
Federal Reserve Bank indicated. The application also will be available 
for inspection at the offices of the Board of Governors. Interested 
persons may express their views in writing on the standards enumerated 
in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the 
acquisition of a nonbanking company, the review also includes whether 
the acquisition of the nonbanking company complies with the standards 
in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, 
nonbanking activities will be conducted throughout the United States. 
Additional information on all bank holding companies may be obtained 
from the National Information Center website at www.ffiec.gov/nic/.
    Unless otherwise noted, comments regarding each of these 
applications must be received at the Reserve Bank indicated or the 
offices of the Board of Governors not later than December 6, 2004.
    A. Federal Reserve Bank of Atlanta (Sue Costello, Vice President) 
1000 Peachtree Street, N.E., Atlanta, Georgia 30303:
    1. CBS Financial Corporation, Smyrna, Georgia; to become a bank 
holding company by acquiring 100 percent of the voting shares of 
Community Bank of the South, Smyrna, Georgia.
    B. Federal Reserve Bank of St. Louis (Randall C. Sumner, Vice 
President) 411 Locust Street, St. Louis, Missouri 63166-2034:
    1. Centennial Bancshares, Inc., Little Rock, Arkansas; to become a 
bank holding company by acquiring 100 percent of the voting shares of 
Pine State Bancshares, Inc., Kingsland, Arkansas, and thereby 
indirectly acquire Pine State Bank, Kingsland, Arkansas.

    Board of Governors of the Federal Reserve System, November 8, 
2004.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 04-25268 Filed 11-12-04; 8:45 am]
BILLING CODE 6210-01-S
[Federal Register Volume 84, Number 20 (Wednesday, January 30, 2019)]
[Notices]
[Page 479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00242]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Cell Biology Integrated Review Group; 
Intercellular Interactions Study Section.
    Date: February 14, 2019.
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, 
Bethesda, MD 20814.
    Contact Person: Thomas Y. Cho, Ph.D., Scientific Review Officer, 
Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 
20892, 301-402-4179, <a href="/cdn-cgi/l/email-protection#1f6b7770727e6c317c77705f71767731787069"><span class="__cf_email__" data-cfemail="c2b6aaadafa3b1eca1aaad82acabaaeca5adb4">[email protected]</span></a>.

    This meeting notice is being published less than 15 days in 
advance of the meeting due to the partial Government shutdown of 
December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 23, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-00242 Filed 1-29-19; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
108TH CONGRESS

1ST SESSION H. R. 2452

AN ACT

To designate the facility of the United States Postal Service located at 339 Hicksville Road in

Bethpage, New York, as the ‘‘Brian C. HickeyPost Office Building’’.

108TH CONGRESS

1ST SESSION H. R. 2452

AN ACT

To designate the facility of the United States Postal Service

located at 339 Hicksville Road in Bethpage, New York,

as the ‘‘Brian C. Hickey Post Office Building’’.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

•HR 2452 EH

1 SECTION 1. DESIGNATION.

2 The facility of the United States Postal Service lo3 cated at 339 Hicksville Road in Bethpage, New York,

4 shall be known and designated as the ‘‘Brian C. Hickey

5 Post Office Building’’.

6 SEC. 2. REFERENCES.

7 Any reference in a law, map, regulation, document,

8 paper, or other record of the United States to the facility

9 referred to in section 1 shall be deemed to be a reference

10 to the ‘‘Brian C. Hickey Post Office Building’’.

Passed the House of Representatives October 8,

2003.

Attest:

Clerk.
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 By Notice dated May 21, 2004, and published in the 
                    **Federal Register**
                     on June 3, 2004, (69 FR 31411), American Radiolabeled Chemicals, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below: Drug
ScheduleGamma hydroxybutyric acid (2010)
IDimethyltryptamine (7435)
IDihydromorphine (9145)
ICocaine (9041)
IICodeine (9050)
IIHydromorphone (9150)
IIBenzoylecgonine (9180)
IIEcgonine (9180)
IIMeperidine (9230)
IIMetazocine (9240)
IIMorphine (9300)
IIOxymorphone (9652)
II
 The company plans to manufacture in bulk, small quantities of the listed controlled substances as radiolabeled compounds. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of American Radiolabeled Chemicals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated American Radiolabeled Chemicals, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: November 1, 2004. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. 04-25103 Filed 11-9-04; 8:45 am] BILLING CODE 4410-09-P
IN THE SUPREME COURT OF THE STATE OF MONTANA No. DA 21
- 0197 IN THE MATTER OF: S.T.S., Respondent and Appellant. **ORDER** Upon consideration of Appellant’s motion for extension of time, and good cause appearing, IT IS HEREBY ORDERED that Appellant is granted an extension of time to and including October 6, 2021 , within which to prepare, file, and serve Appellant’s opening brief on appeal.

Electronically signed by: Mike McGrath Chief Justice, Montana Supreme Court

September 2 2021

09/02/2021

Case Number: DA 21-0197
§ 10.4 Establishment of the Standard Review Committee. ( a ) The Department shall establish and appoint the members of a Standard Review Committee within a reasonable time after receiving a proposed standard. The committee shall consist of qualified representatives of producers, distributors, and users or consumers of product for which a standard is sought or any other appropriate general interest groups such as State and Federal agencies. When requested by the Standard Review Committee, the Department shall appoint one voting member from among the representatives of the Federal agencies, other than the Department of Commerce. All other representatives of Federal agencies on the Standard Review Committees shall be advisory nonvoting members. (Alternates to committee members may be designated by the Department.) When deemed appropriate by the Department, project funds under § 10.2 may be made available to assure participation by consumer interests on the committee at required meetings.
( b ) A Standard Review Committee may remain in existence for a period necessary for the final development of the standard, or for 2 years, whichever is less.
( c ) The Department shall be responsible for the organization of the committee. Any formal operating procedures developed by the committee shall be subject to approval by the Department. The committee may conduct business either in a meeting or through correspondence, but only if a quorum participates. A quorum shall consist of two-thirds of all voting members of the committee. A majority of the voting members of the committee participating shall be required to approve any actions taken by the committee except for the action of recommending a standard to the Department, the requirements for which are contained in § 10.5(b).
COURT OF APPEALS

SECOND DISTRICT OF TEXAS

FORT WORTH

NOS. 02-18-00152-CR

 02-18-00153-CR

MICHAEL RAMIREZ APPELLANT

V.

THE STATE OF TEXAS STATE

------------

FROM THE COUNTY CRIMINAL COURT NO. 1 OF DENTON COUNTY

TRIAL COURT NO. CR-2016-07772-A, CR-2016-08358-A

------------

ORDER

------------

On the court's own motion, it is ORDERED that the trial court clerk deliver

the originals State's Exhibit No. 26 (Officer Holdegraver’s Dashcam Video [Disc

1]), State’s Exhibit No. 27 (Officer Holdegraver’s Dashcam Video [Disc 2]), and

State's Exhibit No. 28 (Officer Holdegraver’s Dashcam Video [Disc 3]), no later

than Thursday, May 10, 2018.

These exhibits will be returned to the trial court clerk upon issuance of the

mandate.

FILE COPY
2

The clerk of this court is directed to transmit a copy of this order to the

attorneys of record, the trial court judge, the trial court clerk, and the court

reporter.

DATED May 3, 2018.

PER CURIAM

FILE COPY
RUSSIA DRAFTSLABELING RULES

----
Exhibit 32.2



CERTIFICATION BY SCOTT W. BRICKMAN



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report on Form 10-Q of The Brickman Group, Ltd. (the Company) for the quarterly period ended September 30, 2004, as filed
with the Securities and Exchange Commission on the date hereof (the Report), Scott W. Brickman, as Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the
Sarbanes-Oxley Act of 2002, that:



1. The Report fully
complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: November 8, 2004



|                        
|------------------------
|/S/    SCOTT W. BRICKMAN
|Scott W. Brickman       
|Chief Executive Officer 



This certification accompanies each
Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.



A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and
furnished to the Securities and Exchange Commission or its staff upon request.
# L_2022267EN.01003401.xml

| 13.10.2022 | EN | Official Journal of the European Union | L 267/34 |
| --- | --- | --- | --- |

13.10.2022

EN

Official Journal of the European Union

L 267/34

---

DECISION OF THE EEA JOINT COMMITTEE No 185/2022

of 10 June 2022

amending Annex IX (Financial services) to the EEA Agreement [2022/1885]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Delegated Regulation (EU) 2020/1989 of 6 November 2020 amending Delegated Regulation (EU) 2019/815 as regards the 2020 update of the taxonomy laid down in the regulatory technical standards for the single electronic reporting format (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Delegated Regulation (EU) 2020/1989 of 6 November 2020 amending Delegated Regulation (EU) 2019/815 as regards the 2020 update of the taxonomy laid down in the regulatory technical standards for the single electronic reporting format (1) is to be incorporated into the EEA Agreement.

| (2) | Annex IX to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex IX to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 29dd (Commission Delegated Regulation (EU) 2019/815) of Annex IX to the EEA Agreement:

| ‘— | 32020 R 1989: Commission Delegated Regulation (EU) 2020/1989 of 6 November 2020 (OJ L 429, 18.12.2020, p. 1).’ |
| --- | --- |

‘—

32020 R 1989: Commission Delegated Regulation (EU) 2020/1989 of 6 November 2020 (OJ L 429, 18.12.2020, p. 1).’

Article 2

The text of Delegated Regulation (EU) 2020/1989 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 11 June 2022, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*), or on the day of the entry into force of Decision of the EEA Joint Committee No 82/2020 of 12 June 2020 (2), whichever is the later.

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 10 June 2022.

For the EEA Joint Committee

The President

Nicolas VON LINGEN

---

(1)  
  OJ L 429, 18.12.2020, p. 1.

1

(*)  No constitutional requirements indicated.

*

(2)  Not yet published in Official Journal.

2

---
#### § 610.123 Travel on official time.

Insofar as practicable travel during nonduty hours shall not be required of an employee. When it is essential that this be required and the employee may not be paid overtime under § 550.112(e) of this chapter the official concerned shall record his reasons for ordering travel at those hours and shall, upon request, furnish a copy of his statement to the employee concerned.
[Federal Register Volume 69, Number 221 (Wednesday, November 17, 2004)]
[Notices]
[Pages 67359-67360]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-25454]


=======================================================================
-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Change in Bank Control Notices; Acquisition of Shares of Bank or 
Bank Holding Companies

    The notificants listed below have applied under the Change in Bank 
Control Act (12 U.S.C. 1817(j)) and Sec.  225.41 of the Board's 
Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. 
The factors that are considered in acting on the notices are set forth 
in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).
    The notices are available for immediate inspection at the Federal 
Reserve Bank indicated. The notices also will be available for 
inspection at the office of the Board of Governors. Interested persons 
may express their views in writing to the Reserve Bank indicated for 
that notice or to the offices of the Board of Governors. Comments must 
be received not later than November 30, 2004.
    A. Federal Reserve Bank of Atlanta (Sue Costello, Vice President) 
1000 Peachtree Street, N.E., Atlanta, Georgia 30303:
    1. CM/FS Reeves Investment, L.P.; Frances Skiller Reeves; Charles 
Monroe Reeves; all of West Point, Georgia, and Steven deRalph Townson, 
Chelsea, Alabama; to acquire voting shares of Frontier National 
Corporation, Sylacauga, Alabama, and thereby indirectly acquire voting 
shares of Frontier Bank, La Grange, Georgia.


[[Page 67360]]


    Board of Governors of the Federal Reserve System, November 10, 
2004.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 04-25454 Filed 11-16-04; 8:45 am]
BILLING CODE 6210-01-S
<PAGE>

                                                                    EXHIBIT 13.1

                                906 Certification

Securities and Exchange Commission
450 Fifth Street, N.W
Washington, D.C. 20549

Ladies and Gentlemen:

     The certificate set forth below is being submitted in connection with the
Annual Report on Form 20-F for the year ended December 31, 2003, (the "Report")
for the purpose of complying with the Rule 13a-14(b) or Rule 15d-14(b) of the
Securities Exchange Act of 1934 (the "Exchange Act") and Section 1350 of Chapter
63 of Title 18 of the United States Code.

     Michael Tong, the Executive Director* of NetEase.com, Inc., certifies that,
to the best of his knowledge:

     1.   the Report fully complies with the requirements of Section 13(a) or
          15(d) of the Exchange Act; and

     2.   the information contained in the Report fairly presents, in all
          material respect, the financial condition and results of operations of
          NetEase, Inc.

Date: June 25, 2004



                                                    By: /s/ Michael Tong
                                                        ------------------------
                                                    Name: Michael Tong
                                                    Title: Executive Director

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to NetEase.com, Inc. and will be
retained by NetEase.com, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.

----------
* Our Acting Chief Executive Officer, Ted Sun, is currently on temporary medical
leave of absence, and our Executive Director has made this certification in his
absence.